biOasis Technologies Inc. to Present at the 1st Annual Neuroscience BioPartnering and Investment …

biOasis to Showcase Their Novel Transcend Technology for the Transport of Drugs in Therapeutic Doses Across the Blood-Brain Barrier (BBB) VANCOUVER, BC–(Marketwired – February 11, 2016) – BIOASIS TECHNOLOGIES INC. (OTCQX: BIOAF)(TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB), announced today that it will be presenting at the 1st Annual Neuroscience Biopartnering and Investment Forum in New York on February 23, 2016. A focus of the forum is on neurodegenerative and orphan diseases, areas where the biOasis BBB technology has shown significant potential. biOasis has also been asked to participate in the panel discussion on Rare and Orphan Diseases at the conference. This panel will be led by Dr. Mark Day from Alexion Pharmaceuticals. Dr. Reinhard Gabathuler,…


Link to Full Article: biOasis Technologies Inc. to Present at the 1st Annual Neuroscience BioPartnering and Investment …